Can a common diabetes drug help heart and kidney patients? small study aims to find out
NCT ID NCT06111768
First seen Jan 05, 2026 · Last updated May 13, 2026 · Updated 23 times
Summary
This study looks at whether adding a type of diabetes medicine (SGLT2 inhibitor) to standard care can help people with acute heart failure who also develop kidney injury. The main goal is to see if it's possible to run a larger trial, so researchers are checking how many patients agree to join and provide samples. About 30 adults with heart failure and high NT-proBNP levels are being enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIORENAL SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.